Products for Research Use Only

Rhosin

CAT: 0804-HY-12646A-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-12646A-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Rhosin is a potent, specific RhoA subfamily Rho GTPases inhibitor, which specifically binds to RhoA to inhibit RhoA-GEF interaction with a Kd of ~ 0.4 uM, and does not interact with Cdc42 or Rac1, nor the GEF, LARG. Rhosin induces cell apoptosis[1][2]. Rhosin promotes stress resiliency through enhancing D1-MSN plasticity and reducing hyperexcitability[3].
CAS Number
1173671-63-0
UNSPSC
12352005
Hazard Statement
H315, H319, H320
Target
Apoptosis; Ras
Type
Reference compound
Related Pathways
Apoptosis; GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Rhosin.html
Concentration
10mM
Purity
98.74
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(N/N=C/C1=CC=C2N=CC=NC2=C1)[C@H](N)CC3=CNC4=C3C=CC=C4
Molecular Formula
C20H18N6O
Molecular Weight
358.40
Precautions
H315, H319, H320
References & Citations
[1]Shang X, et al. Rational design of small molecule inhibitors targeting RhoA subfamily Rho GTPases. Chem Biol. 2012 Jun 22;19 (6) :699-710.|[2]Shang X, et al. Small-molecule inhibitors targeting G-protein-coupled Rho guanine nucleotide exchange factors. Proc Natl Acad Sci U S A. 2013 Feb 19;110 (8) :3155-60.|[3]Francis TC, et al. The Selective RhoA Inhibitor Rhosin Promotes Stress Resiliency Through Enhancing D1-Medium Spiny Neuron Plasticity and Reducing Hyperexcitability. Biol Psychiatry. 2019;85 (12) :1001-1010.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Citation 01
Anticancer Drugs. 2025 Oct 16.|Antioxidants (Basel) . 2022 Jun 27;11 (7) :1264.|Biochem Biophys Res Commun. 2019 Oct 29;519 (1) :134-140.|Cancer Res. 2022 Feb 15;82 (4) :681-694.|Cell Death Dis. 2023 Apr 20;14 (4) :280.|Cell Mol Bioeng. 2022 Oct 6;15 (6) :599-609.|Cell Rep. 2025 Nov 25;44 (11) :116505.|Chem Biol Interact. 2021 Oct 1:348:109625.|Eur J Med Res. 2025 Nov 26;30 (1) :1187.|Exp Cell Res. 2024 Mar 1;436 (1) :113956.|J Breast Cancer. 2019 Apr 22;22 (2) :185-195. |Neuron. 2025 Nov 26:S0896-6273 (25) 00842-6.|SSRN. 2024 Feb 13.|Acta Pharmacol Sin. 2024 Jun;45 (6) :1201-1213.|Biochem Pharmacol. 2023 Nov:217:115816.|bioRxiv. 2023 Oct 16.|bioRxiv. 2025 Mar 4:2025.02.27.640687.|Cancer Biol Ther. 2018;19 (12) :1193-1203.|Cell Death Dis. 2025 Jan 20;16 (1) :31.|Circulation. 2021 May 4;143 (18) :1775-1792.|Ecotoxicol Environ Saf. 2022 May 1;236:113454.|Ecotoxicol Environ Saf. 2023 Jun 1:257:114940.|Endocrinology. 2021 Aug 1;162 (8) :bqab077.|Exp Mol Med. 2025 May;57 (5) :1064-1077.|FASEB J. 2020 Jan;34 (1) :1481-1496.|J Clin Invest. 2025 Jun 2;135 (11) :e184158.|J Mol Med (Berl) . 2023 Dec;101 (12) :1567-1585.|J Virol. 2024 Dec 31:e0140824.|Kardiol Pol. 2021;79 (9) :972-979.|Life Sci Alliance. 2024 Oct 28;8 (1) :e202402585.|Microcirculation. 2021 May;28 (4) :e12680.|Nat Commun. 2023 Mar 14;14 (1) :1402.|Nat Commun. 2025 Mar 22;16 (1) :2821.|Nature. 2025 Sep;645 (8079) :244-253.|Oncol Rep. 2021 Jan;45 (1) :83-94.|Redox Biol. 2025 May:82:103596.|Theranostics. 2022 May 9;12 (8) :3847-3861.|Toxicology. 2024 Nov 9:509:153994.

Chemical Information

Rhosin

Rhosin is a D-tryptophan derivative obtained by formal condensation of the carboxy group of D-tryptophan with the amino group of (quinoxalin-6-yl)methylidenehydrazide. It directly targets the Rho GEF binding domain, thereby preventing Rho from interacting with its GEFs. It has a role as a RhoA inhibitor, a RhoC inhibitor and an antineoplastic agent. It is a hydrazone, a quinoxaline derivative and a D-tryptophan derivative.

CAS Number1173671-63-0
PubChem CID9552914
IUPAC Name(2R)-2-amino-3-(1H-indol-3-yl)-N-[(E)-quinoxalin-6-ylmethylideneamino]propanamide
Molecular FormulaC20H18N6O
Molecular Weight358.4
XLogP1.7
Topological Polar Surface Area109
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count5
Rotatable Bond Count5
Heavy Atom Count27
Formal Charge0
Complexity541
SMILES
C1=CC=C2C(=C1)C(=CN2)C[C@H](C(=O)N/N=C/C3=CC4=NC=CN=C4C=C3)N
InChI
InChI=1S/C20H18N6O/c21-16(10-14-12-24-17-4-2-1-3-15(14)17)20(27)26-25-11-13-5-6-18-19(9-13)23-8-7-22-18/h1-9,11-12,16,24H,10,21H2,(H,26,27)/b25-11+/t16-/m1/s1
InChIKey
FGYHLIHEFHCMPP-FVWOBLMASA-N
Chemical Structure
2D Structure
2D structure of Rhosin
CAS: 1173671-63-0
CID: 9552914
Formula: C20H18N6O
MW: 358.4
Interactive 3D Structure
Loading 3D structure...
Computed Properties
PropertyValue
Molecular Weight358.4
XLogP31.7
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count5
Rotatable Bond Count5
Exact Mass358.15420922
Monoisotopic Mass358.15420922
Topological Polar Surface Area109 Ų
Heavy Atom Count27
Formal Charge0
Complexity541
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes